OKYO NASDAQ
OKYO Pharma Limited
1W: +6.5%
1M: -9.3%
3M: -8.7%
YTD: -34.1%
1Y: -26.9%
3Y: -22.6%
$1.47
+0.13 (+9.70%)
Weekly Expected Move ±7.9%
$1
$1
$1
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider+$0.1M
Congress—
ETF Holdings—
Key Statistics
Market Cap$56.4M
52W Range1.26-3.2
Volume82,517
Avg Volume94,096
Beta0.04
Dividend—
Analyst Ratings
Company Info
CEORobert J. Dempsey
Employees5
SectorHealthcare
IndustryBiotechnology
IPO Date2022-05-17
Websiteokyopharma.com
35a Albemarle St
London, GL W1S 4JE
GB
London, GL W1S 4JE
GB
44 20 7495 2379
About OKYO Pharma Limited
OKYO Pharma Limited is a biopharmaceutical firm operating at the preclinical stage, dedicated to developing innovative treatments for individuals in the United Kingdom experiencing inflammatory eye conditions and ocular discomfort. Its primary therapeutic candidate is OK-101, specifically designed to address dry eye disease. Additionally, the company is advancing OK-201, an experimental bovine adrenal medulla lipidated-peptide analogue, intended to treat neuropathic ocular pain. Established in 2007, OKYO Pharma Limited maintains its headquarters in London, UK.
Latest News
OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain
What Makes OKYO Pharma (OKYO) a New Buy Stock
OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD
12 Health Care Stocks Moving In Tuesday's After-Market Session
9 Health Care Stocks Moving In Wednesday's Pre-Market Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Patil Rajkumar V. | 59,616 | $2.13 | 2026-07-29 | |
| Patil Rajkumar V. | 6,667 | $1.46 | 2026-07-29 | |
| Patil Rajkumar V. | 9,103 | $1.60 | 2026-07-29 | |
| Patil Rajkumar V. | 18,500 | $1.50 | 2026-07-29 | |
| Patil Rajkumar V. | P-Purchase | 3,363 | $1.49 | 2026-07-27 |